SKIN vs TCMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

SKIN

62.9
AI Score
VS
SKIN Wins

TCMD

60.5
AI Score

Investment Advisor Scores

SKIN

Aug 23, 2026
63score
Recommendation
HOLD

TCMD

Aug 23, 2026
61score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SKIN TCMD Winner
Forward P/E 106.383 19.1205 TCMD
PEG Ratio 0.9262 17.792 SKIN
Revenue Growth -7.8% 8.6% TCMD
Earnings Growth 0.0% 144.1% TCMD
Tradestie Score 62.9/100 60.5/100 SKIN
Profit Margin -9.8% 7.1% TCMD
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SKIN 1M: -11.7% · 3M: -1.0% TCMD 1M: -13.2% · 3M: -7.1%

Current Technical Phase

SKIN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.4 · Price: $0.65

TCMD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.9 · Price: $23.82

Fundamentals Snapshot

Metric SKIN TCMD
Market Cap
Forward P/E 4.4 16.1
Trailing P/E 22.3
Revenue (TTM)
Revenue Growth -0.1% 0.1%
Gross Margin 0.7% 0.8%
Operating Margin 0.0% 0.1%
EPS -0.24 1.07
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SKIN is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.